P3373
Systematic adjudication of myocardial infarction end-points in an international clinical trialDisagreements between central clinical events committee and site investigator assessments of myocardial infarction endpoints in an international clinical trial: review of the PURSUIT studyCatheter-based interventions for acute ischaemic strokeIschaemic stroke and ST-segment elevation myocardial infarction: fast-track single-stop approachComparison of cationic propyl gallate and adenosine diphosphate for the measurement of aspirin effectivity with optical aggregometryThe incidence, treatment strategies and outcomes of acute coronary syndromes in the "reperfusion network" of different hospital types in the Czech Republic: results of the Czech evaluation of acute coronary syndromes in hospitalizeSpectrum and clinical manifestations of mutations in genes responsible for hypertrophic cardiomyopathyComparison of outcomes in ST-segment depression and ST-segment elevation myocardial infarction patients treated with emergency PCI: data from a multicentre registry.Long-term outcomes of patients receiving zotarolimus-eluting stents in ST elevation myocardial infarction, non-ST elevation acute coronary syndrome, and stable angina: data from the Resolute program.Antithrombotic therapy of patients with atrial fibrillation discharged after major non-cardiac surgery. 1-year follow-up. Sub-analysis of PRAGUE 14 study.Reperfusion therapy for ST elevation acute myocardial infarction in Europe: description of the current situation in 30 countries.Acute heart failure registry from high-volume university hospital ED: comparing European and US data.Universal definition of myocardial infarction.Guidelines for pre-operative cardiac risk assessment and perioperative cardiac management in non-cardiac surgery: the Task Force for Preoperative Cardiac Risk Assessment and Perioperative Cardiac Management in Non-cardiac Surgery of the European SocThrombin-receptor antagonist vorapaxar in acute coronary syndromes.Effect of platelet inhibition with cangrelor during PCI on ischemic events.Real-world safety and effectiveness outcomes of a zotarolimus-eluting stent: final 3-year report of the RESOLUTE International study.How to treat patients with ST-elevation acute myocardial infarction and multi-vessel disease?2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).Serum Dickkopf-1 signaling and calcium deposition in aortic valve are significantly related to the presence of concomitant coronary atherosclerosis in patients with symptomatic calcified aortic stenosisPrimary angioplasty in acute myocardial infarction with right bundle branch block: should new onset right bundle branch block be added to future guidelines as an indication for reperfusion therapy?The additional value of patient-reported health status in predicting 1-year mortality after invasive coronary procedures: a report from the Euro Heart Survey on Coronary Revascularisation.Design and rationale of the PRAGUE-12 trial: a large, prospective, randomized, multicenter trial that compares cardiac surgery with left atrial surgical ablation with cardiac surgery without ablation in patients with coronary and/or valvular heart dTransfer times and outcomes in patients with ST-segment-elevation myocardial infarction undergoing interhospital transfer for primary percutaneous coronary intervention: APEX-AMI insights.Prognostic value of TNF-related apoptosis inducing ligand (TRAIL) in acute coronary syndrome patientsClopidogrel pre-treatment in stable angina: for all patients > 6 h before elective coronary angiography or only for angiographically selected patients a few minutes before PCI? A randomized multicentre trial PRAGUE-8.European guidelines on cardiovascular disease prevention in clinical practice: executive summary. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituteEuropean guidelines on cardiovascular disease prevention in clinical practice: full text. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by repStent for Life Initiative: where are we standing and where are we going?Randomized trial of primary PCI with or without routine manual thrombectomy.Antithrombotic therapy and outcomes of patients with atrial fibrillation following primary percutaneous coronary intervention: results from the APEX-AMI trial.Improving outcomes in patients undergoing percutaneous coronary intervention: role of prasugrel.Clopidogrel before elective percutaneous coronary intervention.Renal disease and acute coronary syndrome.Stent thrombosis--risk assessment and prevention.Expert consensus document from the European Society of Cardiology on catheter-based renal denervation.Cardiac arrhythmias in acute coronary syndromes: position paper from the joint EHRA, ACCA, and EAPCI task force.Anticoagulation with otamixaban and ischemic events in non-ST-segment elevation acute coronary syndromes: the TAO randomized clinical trial.Uric acid, allopurinol therapy, and mortality in patients with acute heart failure--results of the Acute HEart FAilure Database registry.Mortality implications of primary percutaneous coronary intervention treatment delays: insights from the Assessment of Pexelizumab in Acute Myocardial Infarction trial.
P50
Q24805625-6EE87DAF-DDBB-4219-A6EC-8F66B0BF885DQ24805692-E9A191E9-B71A-48D0-B5D5-E567E2CAB2C5Q28079525-8E3F591F-77F9-4113-B2E3-36998348DB4EQ28082597-38B30B44-127C-43D2-A3F3-7FB59C1474C1Q28222261-3F6A4D2C-560B-48F6-B125-EB711E76D1E2Q28222417-86EFCA23-19C5-4092-B8DE-5DDAA7B24133Q28262963-43E6C77D-6B56-4CA2-BC50-0F855316CDCAQ30575258-07A27FAC-61D2-41BD-9AA7-CE1EE15A0DB8Q30632676-A9D2833D-74EE-4EBF-B23F-45307D7346C5Q33724809-8DE303F0-70DE-4213-B50F-AF007DF49B7CQ33788973-827C7605-A6F3-485B-A392-184891A86E91Q33922743-ABA24898-DFDF-4ACD-B434-43482BCAE6DDQ34007701-C1B28744-8F3D-468E-8A7B-8F4C31023AB9Q34092420-2451EE53-95DE-48E1-8919-F4FC05039E38Q34231934-07ABF74A-BD77-4456-8C9D-40A7CB02DD68Q34331909-770A95FA-5D07-499A-B24B-4021622C3DB5Q34548825-A9B3A025-FA12-4B9A-9DF9-21480CC43C9FQ34571245-1433CFC1-F792-4388-818C-187995FB813DQ34636529-A80CB4E4-1512-4FCD-9273-E68A0FF2A27DQ35107730-7EFEDCC1-5FDC-4C4C-908B-3F585FF64423Q35644244-B0854F07-F784-428A-BDC4-0C074456F1DCQ35773247-FB7D94AC-A9B1-4F78-A073-D2E6A6BFC73DQ36587561-FD8DAE83-55A1-4A58-A466-9E9DC77D716EQ36607921-AF0AF149-48EE-49D0-85D2-5897EFD7BEBFQ36618290-5094C4EB-B675-449E-8286-EA8F37CA3236Q36724610-69790C59-87AE-494E-921B-8956A9D16D74Q36921887-60DD1ECD-012C-4F2D-8B0F-CFB40A5E653DQ36921892-5BAA1338-89B5-4524-8359-EF70D9C05C12Q37140949-1A23863C-C717-4894-9E98-10168F933404Q37198036-92E33B25-3756-406B-B93E-6C693286C336Q37394525-39805596-3F4E-4C13-8B95-8129C4005D9CQ37498604-C3C88578-FBDE-47FD-B554-C8F3C8155776Q37605466-17770EF6-51B5-4D2D-8386-B6E5A3C68F55Q37658108-1D78905A-F1F4-4EFC-BAAD-C6FE328A51D8Q37765611-26284D69-E299-42A5-B60B-A68FAB405FFFQ38101920-A8878408-93E8-4CF6-930F-57841BA0CF10Q38244795-33437A39-FD4F-45C7-80DB-540991F4BF41Q38445390-6242049B-A29C-4133-8AB6-88ED620B6046Q38469629-9D95CB22-D32B-4405-9116-F9F3B0ADFB42Q38494888-9F0F5998-3B4A-4598-8976-6882A6E9F3EE
P50
description
Czech internist, cardiologist, doctor and scientist
@en
dokter
@id
pedagoog
@nl
český internista, kardiolog, lékař a vědec
@cs
name
Petr Widimsky
@sq
Petr Widimský
@cs
Petr Widimský
@en
Petr Widimský
@es
Petr Widimský
@fr
Petr Widimský
@ga
Petr Widimský
@sk
Petr Widimský
@sl
type
label
Petr Widimsky
@sq
Petr Widimský
@cs
Petr Widimský
@en
Petr Widimský
@es
Petr Widimský
@fr
Petr Widimský
@ga
Petr Widimský
@sk
Petr Widimský
@sl
altLabel
Petr Widimsky
@en
prof. MUDr. Petr Widimský, DrSc.
@cs
prefLabel
Petr Widimsky
@sq
Petr Widimský
@cs
Petr Widimský
@en
Petr Widimský
@es
Petr Widimský
@fr
Petr Widimský
@ga
Petr Widimský
@sk
Petr Widimský
@sl
P106
P108
P214
P244
P101
P1280
P166
P19
P21
P213
0000 0000 5813 5013
P214
P244
nb2011024258
P31
P3373
P569
1954-03-29T00:00:00Z
P691
jn20000402682
P735
P7859
lccn-nb2011024258